This review aimed to analyze the current state of DL-based PCa diagnosis with a focus on prostate reconstruction, PCa detection/stratification/reconstruction, PSMA-PET diagnosis, and the use of DL in the context of ADT and prostate biopsy, associated challenges, and their clinical implications. The gene discussed is FOLH1; the disease is posterior cortical atrophy.